Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesArray BioPharma Announces Top-Line Results from Rheumatoid Arthritis Phase 2 Trial
Array BioPharma, 09/04/09
Array BioPharma Inc. announced its preliminary analysis of results from a study examining ARRY–162, a small molecule MEK inhibitor, in a 12–week Phase 2 clinical trial with 201 patients. The patients had active rheumatoid arthritis that was not completely responsive to methotrexate. This study included a placebo group and three different dose groups of ARRY–162, all on a stable background of methotrexate.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Data Presented at San Antonio Breast Cancer Symposium Demonstrate Treatment with Denosumab is Superior to the Standard of Care
Amgen, 12/10/09
Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors
Journal of Clinical Oncology, 12/10/09
Fyi from human genome sciences: gsk initiates second pivotal phase 3 trial for investigational cardiovascular medication darapladib
Human Genome Sciences, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor